News

In a Phase II trial, Amgen’s investigational therapy MariTide (maridebart cafraglutide) delivered significant, sustained ...
As clinical research increasingly relies on RWD to enhance trial design and patient insights, tokenization has emerged as a ...
Brian Ongioni, chief product officer, uMotif, explains how early patient feedback plays a crucial role in shaping digital ...
Cashin, MD, chief medical officer, Novotech, emphasizes the importance of proactive communication, strategic alignment, and ...
As clinical research increasingly relies on RWD to enhance trial design and patient insights, tokenization has emerged as a critical solution for securely linking disparate datasets while protecting ...